T Rowe Price Group (TROW) 69.27 $TROW After Yesterday's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
T Rowe Price Group (TROW) 69.27 $TROW

After Yesterday's Decline of 1.09%, T Rowe Price Offers Investors Better Value
Comtex SmarTrend(R) - Thu Sep 01, 2:28PM CDT
T Rowe Price (NASDAQ:TROW) traded in a range yesterday that spanned from a low of $68.51 to a high of $69.98. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $68.77 on volume of 400,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TROW: 69.27 (+0.52)

T. Rowe Price Launches New Canadian Pooled Investment Vehicle Within Global Focused Growth Equity Strategy
CNW Group - Wed Aug 24, 9:00AM CDT
Global Focused Growth Equity strategy is now available to Canadian institutional investors through a new pooled vehicle
TROW: 69.27 (+0.52)

T. Rowe Price Group Declares Quarterly Dividend
PR Newswire - Wed Aug 24, 7:28AM CDT
T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced today that its Board of Directors has declared a quarterly dividend of $0.54 per share payable September 29, 2016 to stockholders of record as of the close of business on September 15, 2016.
TROW: 69.27 (+0.52)

Blog Coverage Valeant Pharma Appoints New CEO
ACCESSWIRE - Tue Aug 23, 8:15AM CDT
LONDON, UK / ACCESSWIRE / August 23, 2016 / Active Wall St. blog coverage looks at the headlines from Valeant Pharmaceuticals International, Inc. (NYSE: VRX) and Zoetis Inc. (NYSE: ZTS). Zoetis announced on August 21, 2016, that it had appointed Glenn David as its Executive Vice President and Chief Financial Officer (CFO). The announcement came in the wake of the resignation of Executive Vice President and CFO Paul S. Herendeen on August 18, 2016. On August, 22, 2016, Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced the appointment of Paul S. Herendeen to take on the role of CFO from Robert L. Rosiello. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.
AGN: 235.96 (-1.80), ZTS: 51.26 (+0.15), VRX: 28.76 (-0.36), TROW: 69.27 (+0.52), VRX.TO: 37.34 (-0.75)

Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:21AM CDT
Valeant Pharmaceuticals International, Inc. (VRX) announced that it has received the requisite lender approval for an amendment to its credit facility which is scheduled to close next week.
VRX: 28.76 (-0.36), TROW: 69.27 (+0.52), CORT: 5.31 (-0.04), PCRX: 39.04 (-1.33)

Company News for August 19, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:10AM CDT
Companies in the News are: CSCO,NTAP,HRL,VRX,TROW
VRX: 28.76 (-0.36), TROW: 69.27 (+0.52), HRL: 38.46 (+0.25), NTAP: 34.90 (-0.03), CSCO: 31.83 (+0.25)

T Rowe Price Falls 1.35% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Aug 09, 2:22PM CDT
T Rowe Price (NASDAQ:TROW) traded in a range yesterday that spanned from a low of $68.74 to a high of $69.78. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $68.80 on volume of 699,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TROW: 69.27 (+0.52)

Top 3 Research Reports for August 8, 2016
Sheraz Mian - Zacks Investment Research - Mon Aug 08, 11:27AM CDT
Top 3 Research Reports for August 8, 2016
CAH: 79.73 (+0.03), TROW: 69.27 (+0.52), KHC: 89.61 (+0.13), BAC: 16.00 (+0.02), AET: 116.73 (+0.57), MA: 97.89 (+0.27)

JPMorgan Partners with Virtu to Trade in U.S. Treasuries
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:21AM CDT
Wall Street giant JPMorgan Chase & Co. (JPM) entered into strategic partnership with a leading electronic market maker ??? Virtu Financial, Inc. (VIRT),to gain access and trade in the U.S. Treasuries market
VIRT: 16.27 (-0.19), JPM: 67.49 (+0.28), TROW: 69.27 (+0.52), CMA: 47.58 (+0.55)

Federated Investors (FII): High Revenues Drove Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:02PM CDT
Propelled by lower fee-waivers, Federated Investors, Inc. (FII) delivered a positive earnings surprise in second-quarter 2016, marking the fifth straight quarter of an earnings beat.
FII: 32.75 (+0.67), TROW: 69.27 (+0.52), JNS: 14.75 (+0.09), AMP: 101.11 (+1.22)

Lazard (LAZ) Q2 Earnings Impress on Low Costs, Shares Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 7:37AM CDT
Lazard Ltd. (LAZ) reported a positive surprise of 1.7% in second-quarter 2016 which led to a rise of 3.26% in its share price.
LAZ: 37.33 (+0.53), TROW: 69.27 (+0.52), JNS: 14.75 (+0.09), AMP: 101.11 (+1.22)

Asset Management Stocks Under Investors' Scanner -- T. Rowe Price Group, Ameriprise Financial, Federated Investors, and BlackRock
PR Newswire - Fri Jul 29, 6:50AM CDT
Growth in the Asset Management industry has stalled, as operators continue to address overcapacity issues and high operating costs. Stock-Callers.com looks at how these equities have performed in recent weeks despite these challenges: T. Rowe Price Group Inc. (NASDAQ: TROW), Ameriprise Financial Inc. (NYSE: AMP), Federated Investors Inc. (NYSE: FII), and BlackRock Inc. (NYSE: BLK). Learn more about these stocks by accessing their free notes at:
BLK: 373.85 (+1.68), FII: 32.75 (+0.67), TROW: 69.27 (+0.52), AMP: 101.11 (+1.22)

Franklin (BEN) Reports Impressive Q3 Earnings, Costs Down
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 1:54PM CDT
Franklin Resources Inc. (BEN) recorded a positive earnings surprise of 16.7% in third-quarter fiscal 2016 (ended Jun 30), driven by lower expenses. The company reported earnings of 77 cents per share, surpassing the Zacks Consensus Estimate of 66 cents.
TROW: 69.27 (+0.52), JNS: 14.75 (+0.09), AMP: 101.11 (+1.22), BEN: 36.15 (+0.29)

Legg Mason (LM) Q1 Earnings Miss Estimates on High Costs
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 6:51AM CDT
Legg Mason Inc. (LM) reported negative earnings surprise of 57.5% in the first quarter of fiscal 2017 (ended Jun 30). The company reported net income of 31 cents per share considerably missing the Zacks Consensus Estimate of 73 cents.
TROW: 69.27 (+0.52), JNS: 14.75 (+0.09), AMP: 101.11 (+1.22), LM: 34.78 (+0.73)

Janus Capital (JNS) Stock Up Despite Earnings Miss in Q2
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:05PM CDT
Janus Capital Group, Inc. (JNS) recorded a negative earnings surprise of 4.55% in second-quarter 2016. The company reported earnings per share attributable to common shareholders of 21 cents, missing the Zacks Consensus Estimate by a penny.
TROW: 69.27 (+0.52), IVZ: 31.48 (+0.38), JNS: 14.75 (+0.09), BEN: 36.15 (+0.29)

Zacks Research Daily for June 13, 2016
Sheraz Mian - Zacks Investment Research - Mon Jun 13, 1:26PM CDT
Zacks Research Daily for June 13, 2016
FIT: 14.96 (+0.01), TROW: 69.27 (+0.52), BAC: 16.00 (+0.02), INTC: 36.08 (+0.06), JNPR: 23.41 (+0.10)

T. Rowe Price to Cough Up $194M for the Dell Voting Error
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:14AM CDT
T. Rowe Price Group, Inc. (TROW), one of the biggest mutual-fund companies in the U.S., has arrived at an arrangement per which it will spend about $194 million to recompense certain clients.
APAM: 26.02 (+0.33), SEIC: 45.99 (+0.17), TROW: 69.27 (+0.52), GBL: 30.79 (+0.47)

T. Rowe Price To Compensate Clients For Dell Voting Error
PR Newswire - Mon Jun 06, 1:12PM CDT
NEWS
TROW: 69.27 (+0.52)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chicken Salad Chick's Utah Expansion: The Next Course

Updated Category News Views 209

A New Serving in Spanish Fork Chicken Salad Chick is taking another bite out of the Utah market with the opening of its second location in Spanish Fork. On deck for a November 17 debut, this fast-casual chain is serving up not just chicken salad, but a hefty dose of Southern hospitality and promotional giveaways to boot. The big hook? Be among the first 100 patrons and...

Continue Reading
Good Springs Earns Spot on Inc.'s 2026 Founder List

Updated Category News Views 31

There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....

Continue Reading
Bird-X Welcomes Doolittle to Elevate Sales Strategy

Updated Category News Views 105

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Continue Reading
Hagerty Amplifies Profit Forecast Amid Premium Gains

Updated Category News Views 0

An Unyielding Growth Trajectory Hagerty, Inc. just unveiled its behemoth third quarter results for 2026 and they're nothing if not eye-popping. With a whopping 18% increase in written premium year-over-year to a towering $1,099 million, there's no mistaking Hagerty’s robust growth trajectory. And that's just one piece of the puzzle—earned premiums rocketed up by 42%...

Continue Reading
Wet Noses Innovates Human-Grade Pet Food at PLMA 2026

Updated Category News Views 115

Pet Food Revolution? Wet Noses Takes the PLMA Stage Okay, listen up, pet lovers and industry folks alike—seems like Wet Noses, that Washington-based veteran in the dog treat game, is shaking up the pet food world. After cruising through the pet aisle for almost three decades, they're making a splash at the PLMA 2026. Why should we care? Well, they’re pushing this...

Continue Reading
Novartis Pulls the Plug on BioArctic Agreement

Updated Category News Views 34

Novartis Drops BioArctic Like a Hot Potato Well, folks, it looks like Novartis has decided to pack up its bags and hightail it out of its collaboration with BioArctic AB. This ain't just any small piece of news—it's got ramifications that have folks in the biotech and healthcare sector scratching their heads and, probably, feeling a mixture of apprehension and...

Continue Reading
Truecaller's Strategic Shift: Recovery and Growth in 2026

Updated Category News Views 61

Grappling with Numbers: Truecaller's Q3 2026 Results A glance at Truecaller's latest report tells us they're banking on a strategic recovery.AOver their recent interim report covering January to September 2026, they disclose a modest 1% decrease in net sales reaching SEK 464 million. Now, if you scoop away the currency fluctuations, net sales climb by a soft 3% from Q2....

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 99

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading
Elron Ventures Revamps Leadership to Boost Tech Focus

Updated Category News Views 7

Shaking Up the Leadership Roster The folks over at Elron Ventures are making some big moves, shifting the chess pieces on their leadership board in a bid to bolster their investment and M&A strategy. They're bringing in fresh blood and seasoned vets alike to navigate the rocky waters of Defense Tech, Deep Tech, Cybersecurity, and AI. You reckon they're onto something,...

Continue Reading
Restorative Getaways Aid Grieving Families, Offers Relief

Updated Category News Views 71

Finding Solace in Change: The Power of Stepping Away Grieving a lost child. It’s a trip to hell and back, and for many families, the journey feels endless. The press of everyday life—bills, jobs, commutes—offers no mercy. At times, stepping out of the blur might be the prime move toward healing, and that's where restorative getaways step in. Escaping the Everyday...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from Q1 2025 Insurance Labor Market Webinar

Updated Category News Views 126

Insights from Q1 2025 Insurance Labor Market Webinar Chicago has become a hub for discussions about the future of the insurance industry, especially with the forthcoming webinar highlighting the results of the Q1 2025 Insurance Labor Market Study. This semi-annual study, spearheaded by The Jacobson Group, a notable leader in providing talent within the insurance sector,...

Continue Reading
Essity's Q2 2025 Report: Challenges and Growth Ambitions

Updated Category News Views 551

Organic Growth Amid Economic Challenges Essity's recent quarterly report underscores the company's resilience in the face of a tough economic landscape. Highlighting an organic sales growth of 1.9%, the company's diverse portfolio of hygiene and health products is proving to be a strong foundation during uncertain times. Quarterly Performance Overview The report for the...

Continue Reading
Equifax's Strong 2025 Q2 Performance: Revenue Growth Highlights

Updated Category News Views 508

Equifax Reports Impressive Q2 Financial Results Equifax Inc. (NYSE: EFX) recently delivered its financial outcomes for the latest quarter, demonstrating remarkable performance despite challenging market conditions. The company reported an impressive revenue of $1.537 billion for the second quarter of 2025, reflecting a notable growth rate of 7% on a reported basis and 8%...

Continue Reading
JetBlue Airways Faces Wider Loss but CEO Confident in Recovery

Updated Category News Views 260

JetBlue Airways Reports Wider Loss JetBlue Airways Corp. (NASDAQ: JBLU) announced a net loss of $143 million, translating to a loss of 39 cents per diluted share. This is a significant drop from last year's loss of $60 million, or 17 cents per share, indicating challenges in the current operational climate. Adjusted Earnings and Revenue Performance Despite the reported...

Continue Reading
Investors Urged to Act: Deadline Approaches for Nextracker Claims

Updated Category News Views 155

Understanding the Nextracker Class Action Lawsuit The recent developments regarding Nextracker Inc. have raised significant concerns among investors, particularly those who have suffered substantial financial losses. Kahn Swick & Foti, LLC (KSF), led by former Louisiana Attorney General Charles C. Foti, Jr., is urging affected shareholders to take action before the...

Continue Reading